Stay updated on SL-401 in BPDCN or AML Clinical Trial

Sign up to get notified when there's something new on the SL-401 in BPDCN or AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SL-401 in BPDCN or AML Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    No detectable content changes were provided.
    Difference
    0.0%
    Check dated 2026-04-23T15:15:14.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 on the page.
    Difference
    0.0%
    Check dated 2026-04-16T11:12:00.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Added CD4+/CD56+ hematodermic neoplasm as an additional MeSH term for the study.
    Difference
    0.0%
    Check dated 2026-04-02T05:25:03.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-18T20:20:27.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-11T17:57:18.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the government funding lapse notice and Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T11:00:03.000Z thumbnail image

Stay in the know with updates to SL-401 in BPDCN or AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SL-401 in BPDCN or AML Clinical Trial page.